h2
GERO and FOXO Technologies embark on joint initiative on AI and epigenetic data
h2
Amber Bio raises $26 million for gene editing technology
h2
Advancing human healthspan: Longevity Summit Dublin’s agenda unveiled
h2
Inflammaging discovery could slow aging and prevent age-related diseases
h2
Top 3 reasons longevity companies require a new healthcare marketing strategy to attract investors a
h2
Finding the recipe for success in cell therapy
h2
Can senotherapeutic peptides reduce skin aging?
h2
Ending Age-Related Diseases conference looks to future of longevity
h2
New research ties obesity to sex- and age-specific genes
h2
Swiss longevity company Epiterna exits stealth to tackle aging
h2
MyMD reports positive results in Phase 2 sarcopenia trial
h2
Protein-targeting vaccine signposts Alzheimer’s breakthrough
h2
Publicly traded longevity companies announce new finance
h2
Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more
h2
Stay cool: the longevity tech that “shows insane promise”
h2
Does SIRT6 hold the key to human longevity?
h2
Tally up! Consumer longevity company lands $10m
h2
Inflammaging discovery could slow aging and prevent age-related diseases
h2
New research ties obesity to sex- and age-specific genes
h2
Protein-targeting vaccine signposts Alzheimer’s breakthrough
h2
Eight longevity habits that could lengthen your life by 20 years
h2
Ending Age-Related Diseases conference looks to future of longevity
h2
Swiss longevity company Epiterna exits stealth to tackle aging
h2
Longevity investing: Navigating hype cycles to preserve reputable technologies
h2
Dunedin Study receives £1.4m award to explore midlife aging
h2
Impetus announces $10 million for aging science research grants
h2
Advancing human healthspan: Longevity Summit Dublin’s agenda unveiled
h2
Researchers develop compound that prevents free radical production in mitochondria
h2
Avea secures $5 million in seed funding
h2
Longevity: This time it’s personal
h2
Taurine deficiency: New research identifies possible driver for aging
h2
A strong patent portfolio delivers a competitive edge in the longevity space
h2
Combilytics: Taking a combined approach to senescence
h2
Longevity based on research, education and transparency
h2
Mikra announces successful study results for CELLF
h2
SRW – changing how we experience aging at a cellular level
h2
Combining AI and MRI to improve human longevity
h2
Andrew Steele: Curing aging is a question of investment, not time
h2
SIRT6: The protein that talks the talk and walks the walk
h2
Putting AI to work in cryopreservation
h2
GERO and FOXO Technologies embark on joint initiative on AI and epigenetic data
h2
Amber Bio raises $26 million for gene editing technology
h2
Swiss longevity company Epiterna exits stealth to tackle aging
h2
Publicly traded longevity companies announce new finance
h2
Longevity: This time it’s personal
h2
SIRT6: The protein that talks the talk and walks the walk
h2
Navigate the emerging field of longevity
h2
It’s a brave new world – but longevity needs to stay in the realm of the credible
h2
Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause
h2
A strong patent portfolio delivers a competitive edge in the longevity space
h2
Juvenescence: Think aging up, rather than disease down
h2
Combilytics: Taking a combined approach to senescence
h2
Investing in Longevity 101
h2
Combining AI and MRI to improve human longevity
h2
Vital Biosciences raises $48m for revolutionary blood diagnostic tech
h2
Biostrap exits consumer market with new health monitoring wearable
h2
Beacon Biosignals acquires sleep monitoring technology firm
h2
Altered gut bacteria could be early warning sign of Alzheimer’s
h2
Mitochondrial DNA fragments in blood shown to be important biomarkers for aging
h2
Connected technologies are changing the future of aging at home
h2
AI innovations to transform living with dementia awarded £1.9 million
h2
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
h2
Large study finds brain training can reduce falls in older adults
h2
GERO and FOXO Technologies embark on joint initiative on AI and epigenetic data
h2
Combining AI and MRI to improve human longevity
h2
Biostrap exits consumer market with new health monitoring wearable
h2
Causaly raises $60 million to boost AI-powered preclinical discovery
h2
Subscribe to our newsletter
h2
Finding the recipe for success in cell therapy
h2
MyMD reports positive results in Phase 2 sarcopenia trial
h2
Protein-targeting vaccine signposts Alzheimer’s breakthrough
h2
FOXO Technologies launches bioinformatics services and hopes to revolutionize epigenetic data analys
h2
Focal Biosciences: new cellular reprogramming startup unveiled
h2
Biophytis applies to commence “first ever” Phase 3 sarcopenia trial
h4
No spam - just the good stuff
h4
InvestmentInvestor Portal